Ildong Pharmaceutical jointly sells product licenses with Sandoz in Asian-Pacific regions

Published: 2018-08-27 17:52:52

Updated: 2018-08-27 17:52:52

Ildong Pharmaceutical(CEO Woong-Sup Yoon) will make a strategic alliance with Sandoz, a subsidiary of the global pharmaceutical company Novartis Group.

Ildong Pharmaceutical signed a memorandum of understanding(MOU) for the Sandoz products’ license and sales cooperation in the Asian-Pacific regions, and decided to cooperate for all the circumstances on the 23^rd.

The purpose of the MOU is for ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.